Advertisement
Kura Oncology, Inc. (KURA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
As of 03:48PM EST. Market open.
| Previous Close | 15.92 |
| Open | 15.99 |
| Bid | 15.95 x 300 |
| Ask | 16.07 x 400 |
| Day's Range | 15.75 - 16.68 |
| 52 Week Range | 9.06 - 24.17 |
| Volume | |
| Avg. Volume | 563,007 |
| Market Cap | 1.244B |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.35 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.50 |
GuruFocus.comKura Oncology Inc (KURA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Rising Expenses
Despite increased R&D costs and net loss, Kura Oncology Inc (KURA) showcases promising clinical progress and a robust financial position.
- Associated Press Finance
Kura Oncology: Q3 Earnings Snapshot
SAN DIEGO (AP) — Kura Oncology Inc. KURA) on Thursday reported a loss of $54.4 million in its third quarter. The San Diego-based company said it had a loss of 63 cents per share.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.